Omrix Biopharmaceuticals, Inc. (NASDAQ: OMRI)

Omrix Biopharmaceuticals, Inc. (NASDAQ: OMRI) is dedicated to developing innovative technologies that provide safer and more effective options to patients in areas with significant, but unmet medical needs. The company is primarily focused on the areas of biosurgical and passive immunotherapy products. By utilizing their proprietary protein purification technology, novel development capabilities, and manufacturing expertise, the company aims to develop treatments of choice in their respective therapeutic areas. For further information, visit the Company’s web site at www.omrix.com.